StockStory.org on MSN
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported in Q3 CY2025, with sales up 20% year on year to $850.7 ...
According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing kit in the mail without ordering it yourself: your doctor or health care ...
Editor’s note: This story was updated to clarify recommendations for colorectal cancer screening. As a gastroenterologist, the most meaningful part of my job is preventing colorectal cancer by ...
The Cologuard Plus test is more accurate than the original Cologuard, and should be easier to mail in for stool analysis. The newest version of Cologuard, an at-home colon cancer screening test, ...
Q3 2025 Management View CEO Kevin Conroy reported, "The Exact Sciences team delivered record results in the third quarter.
Q. My doctor prescribed a Cologuard test instead of a colonoscopy. No one mentioned how often Cologuard could result in false positive test results, as mine did. So, a colonoscopy was necessary after ...
Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...
The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...
Mail-in stool kits such as Colorguard can detect warning signs, but gastroenterologists say a colonoscopy is still the most ...
An endoscopist’s knowledge of a positive Cologuard test improved colonoscopy performance, according to a Rochester, Minn.-based Mayo Clinic poster presentation at the 2016 Digestive Disease Week in ...
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
Cologuard Plus is only noninvasive test to be evaluated head-to-head against an independent fecal immunochemical test, which it significantly outperformed 20,000-participant BLUE-C study included 98 ...
Cologuard is getting an upgrade after 10 years on the market, as Exact Sciences starts to roll out the new version of its home screening test for colorectal cancer. The company said the addition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results